Collaboration Details

Title of Collaborative Activity:

NIH-FDA Interagency Clinical Outcome Assessments Working Group (ICOAWG)

Description of Collaborative Activity:

The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

2010

NIH Participating Institutes/Centers/Office of the Director:

NCI, CC, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/DPCPSI

HHS Agency Collaborators on this Activity:

FDA